Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Precision Medicine: At What Price?

× No keyword cloud information.

12 in total

1. Efficacy of lumacaftor-ivacaftor for the treatment of cystic fibrosis patients homozygous for the F508del-CFTR mutation.

Authors: Deborah M Cholon; Charles R Esther; Martina Gentzsch
Journal: Expert Rev Precis Med Drug Dev Date: 2016-04-22

2. Development of HPLC and LC-MS/MS methods for the analysis of ivacaftor, its major metabolites and lumacaftor in plasma and sputum of cystic fibrosis patients treated with ORKAMBI or KALYDECO.

Authors: Elena K Schneider; Felisa Reyes-Ortega; John W Wilson; Tom Kotsimbos; Dominic Keating; Jian Li; Tony Velkov
Journal: J Chromatogr B Analyt Technol Biomed Life Sci Date: 2016-10-24 Impact factor: 3.205

Review 3. Toward precision medicine and health: Opportunities and challenges in allergic diseases.

Authors: Stephen Joseph Galli
Journal: J Allergy Clin Immunol Date: 2016-05 Impact factor: 10.793

Review 4. Academic, Foundation, and Industry Collaboration in Finding New Therapies.

Authors: Bonnie W Ramsey; Gerald T Nepom; Sagar Lonial
Journal: N Engl J Med Date: 2017-05-04 Impact factor: 91.245

Review 5. Lumacaftor/ivacaftor combination for cystic fibrosis patients homozygous for Phe508del-CFTR.

Authors: W Zhang; X Zhang; Y H Zhang; D C Strokes; A P Naren
Journal: Drugs Today (Barc) Date: 2016-04 Impact factor: 2.245

6. Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine.

Authors: Heleen Vellekoop; Simone Huygens; Matthijs Versteegh; László Szilberhorn; Tamás Zelei; Balázs Nagy; Rositsa Koleva-Kolarova; Apostolos Tsiachristas; Sarah Wordsworth; Maureen Rutten-van Mölken
Journal: Pharmacoeconomics Date: 2021-04-16 Impact factor: 4.981

Review 7. Left behind: The potential impact of CFTR modulators on racial and ethnic disparities in cystic fibrosis.

Authors: Meghan E McGarry; Elizabeth R Gibb; Gabriela R Oates; Michael S Schechter
Journal: Paediatr Respir Rev Date: 2021-12-22 Impact factor: 5.526

Review 8. Strategies for the etiological therapy of cystic fibrosis.

Authors: Luigi Maiuri; Valeria Raia; Guido Kroemer
Journal: Cell Death Differ Date: 2017-09-22 Impact factor: 15.828

Review 9. Transition to adulthood and adult health care for patients with sickle cell disease or cystic fibrosis: Current practices and research priorities.

Authors: Sophie Lanzkron; Gregory S Sawicki; Kathryn L Hassell; Michael W Konstan; Robert I Liem; Susanna A McColley
Journal: J Clin Transl Sci Date: 2018-10

Review 10. Personalized or Precision Medicine? The Example of Cystic Fibrosis.

Authors: Fernando A L Marson; Carmen S Bertuzzo; José D Ribeiro
Journal: Front Pharmacol Date: 2017-06-20 Impact factor: 5.810